A detailed history of Credit Suisse Ag transactions in Iradimed Corp stock. As of the latest transaction made, Credit Suisse Ag holds 12,031 shares of IRMD stock, worth $650,516. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,031
Previous 12,031 -0.0%
Holding current value
$650,516
Previous $571,000 7.36%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

BUY
$37.31 - $47.47 $255,536 - $325,122
6,849 Added 132.17%
12,031 $571,000
Q3 2023

Nov 13, 2023

BUY
$43.28 - $50.3 $224,276 - $260,654
5,182 New
5,182 $229,000
Q3 2022

Nov 10, 2022

BUY
$29.42 - $42.25 $970 - $1,394
33 Added 550.0%
39 $1,000
Q2 2022

Aug 12, 2022

BUY
$30.15 - $45.79 $180 - $274
6 New
6 $0

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $679M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.